IGM Biosciences to Present at the 2020 RBC Capital Markets Global Healthcare Conference
MOUNTAIN VIEW, Calif., May 12, 2020 (GLOBE NEWSWIRE) — IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on […]
Agios to Present at the RBC Capital Markets Global Healthcare Virtual Conference on Tuesday, May 19, 2020
CAMBRIDGE, Mass., May 12, 2020 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism […]
Applied Therapeutics to Present at the UBS Global Healthcare Conference
NEW YORK, May 12, 2020 (GLOBE NEWSWIRE) — Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline […]
EHang to Participate in the 5th Annual Oppenheimer Emerging Growth Conference on May 12, 2020
GUANGZHOU, China, May 12, 2020 (GLOBE NEWSWIRE) — EHang Holdings Limited (Nasdaq: EH) (“EHang” or the “Company”), the world’s leading […]
Endeavour Silver Releases 2019 Annual Review and Sustainability Report
VANCOUVER, British Columbia, May 12, 2020 (GLOBE NEWSWIRE) — Endeavour Silver Corp. (NYSE: EXK) (TSX: EDR) announces the publication of […]
TSX News -
Freight Forwarders Mitigate COVID-19 Ocean Shipment Disruptions Using Cloud-based Descartes Solutions
WATERLOO, Ontario, May 12, 2020 (GLOBE NEWSWIRE) — Descartes Systems Group (Nasdaq: DSGX) (TSX:DSG), the global leader in uniting logistics-intensive […]
Beam Therapeutics Reports Additional Data at ASGCT Annual Meeting and First Quarter 2020 Financial Results
Alpha-1 Antitrypsin Deficiency Program Demonstrates More than Four-Fold Increase in Circulating Levels of Functional Protein Following Durable Direct Correction In […]
TSX News -
ProMIS Neurosciences identifies multiple novel targets on SARS CoV-2 for development of a highly accurate COVID-19 antibody test
TORONTO, Ontario and CAMBRIDGE, Mass., May 12, 2020 (GLOBE NEWSWIRE) — ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a company […]
BriaCell Continues Business and Clinical Operations During COVID-19 Pandemic
Phase I/IIa clinical study of BriaCell’s lead candidate, Bria-IMT™, for breast cancer treatment, with Incyte Corporation’s immune checkpoint inhibitor, INCMGA00012, […]
Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2020
CAMBRIDGE, Mass., May 12, 2020 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target […]
